Osteoporosis sufferers could benefit from new jab that can rebuild crumbly bones

In a clinical trial, four of 800 patients with osteoporosis had a spine fracture while taking new drug abaloparatide after 18 months compared with six taking a standard treatment, Forteo.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news